Pillstats
Rx only · Capsule · Oral

Lisdexamfetamine Dimesylate

Brands: Vyvanse · Lisdexamfetamine Dimesylate

15 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US105 NDCs
15 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers15 labelers
Packages116
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 97 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.13$2.26$3.40$4.53Dec 2025Feb 2026Jun 2026
$3.586
Latest avg · Jun 17, 2026
-9%
Since Dec 17, 2025
15
Active US suppliers
22%
Top-2 supplier share*

Who makes it15 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager19SUPPLYING
Lannett Company, Inc.unknown7SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown7SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown7SUPPLYING
Sandoz Incunknown7SUPPLYING
SpecGx LLCunknown7SUPPLYING
Takeda Pharmaceuticals America, Inc.unknown7SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown7SUPPLYING
Granules Pharmaceuticals Incunknown7SUPPLYING
Camber Pharmaceuticals, Inc.unknown7SUPPLYING
Rhodes Pharmaceuticals LLCunknown7SUPPLYING
Alvogen Inc.unknown7SUPPLYING
Apotex Corp.unknown7SUPPLYING
Elite Laboratories, Incunknown7SUPPLYING
American Health Packagingunknown6SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.